Mushroom Beta-Glucan COAs: Read Total and Alpha-Glucan Too

Imagine a mushroom buyer asking GreenLand to compare two COAs prepared with different hydrolysis routes and wet or dry reporting bases. This hypothetical enquiry needs more than the two final numbers. We would request the actual mushroom form, method version, total and alpha results, and the basis of each percentage. Those records help determine whether the buyer is seeing a material difference, a method difference or an unresolved comparison.

Define the mushroom sample and analyte

Start with what was tested. Whole edible fruit bodies, mycelial material, a dried powder and an extract are different samples. They may contain different constituents and have undergone different preparation. A COA headed only "mushroom" does not provide enough information for a sourcing comparison. State species, material form and relevant processing so that the result belongs to a clearly identified ingredient rather than to an indistinct product category.

This distinction is especially important when a buyer searches broadly for beta-glucan information. A result from a medicinal-mushroom extract should not become an expected composition for frozen edible nameko. An extracted ingredient is also different from the food ingredient used in a soup, sauce or meal. GreenLand's frozen nameko enquiry concerns the verified edible-mushroom form requested by the buyer; a research discussion does not create an offered extract or supplement product.

Whole frozen nameko mushrooms showing caps and pale stems.

Define the analyte as carefully as the sample. Beta-glucan, total glucan and total polysaccharides are different analytical descriptions. A broad polysaccharide result cannot be relabeled as beta-glucan without a method that supports that interpretation. Likewise, an assay expressed as glucose after a particular hydrolysis needs its calculation and reporting conventions explained. The name on the COA should correspond to what the validated method actually determines.

The reporting basis is the next essential field. A percentage on an as-received basis includes the sample's moisture context. A percentage on a dry-matter basis expresses the result relative to dry material. Two values on those different bases cannot be ranked directly. Ask whether the laboratory measured moisture, which sample supplied that measurement and how any conversion was performed. Do not estimate the conversion from a generic moisture value for the species.

For an illustrative example only, consider 100 grams of a sample containing 10 grams of dry matter and one gram of the measured analyte. That would be one percent on the original sample basis and ten percent on the dry-matter basis. These are two expressions of the same hypothetical amount, not composition figures for nameko or a GreenLand product. The example shows why basis must be aligned before interpreting a large percentage difference.

Sample preparation also affects what enters the assay. A laboratory should identify whether it analyzed a representative homogenized sample, selected pieces, dried material or a separated fraction. For a frozen mushroom input, ask how thawed liquid was handled if it matters to the reported sample. An analysis of selected caps or a drained fraction should be described accordingly. It is not automatically an analysis of the complete supplied material.

Illustrative arithmetic: 1 g analyte in 100 g original material is 1% as received; in 10 g dry matter it is 10% dry basis. Shapes are schematic.

The purpose of the enquiry should determine whether this assay is needed. A buyer sourcing intact mushrooms for a prepared meal may primarily require species, size, sensory quality, packing and other agreed food-quality records. A compositional project may need an additional defined assay. The existence of a percentage on another supplier's COA is not by itself a reason to impose the same requirement on every edible-mushroom purchase.

At GreenLand, we would ask the hypothetical buyer to identify the intended food use and the two samples behind the reports. That conversation can establish whether the buyer is comparing equivalent ingredient forms. It also separates a supply question from an analytical-development question. A useful comparison begins with those boundaries; otherwise, a well-presented extract COA can distract from the requirements of an ordinary frozen edible-mushroom program.

If the submitted material contains additional ingredients, identify them for the laboratory and in the comparison record. A mushroom blend, formulated powder or coated food is a different analytical matrix from an isolated fruit body. The laboratory may need to assess relevant interferences and preparation. The buyer should not remove those details to make two certificates appear equivalent. A clear material description can explain why a method suitable for one product requires further qualification for another.

How total and alpha results enter the calculation

In the method examined by McCleary and Draga, the beta-glucan result is obtained by difference between separately determined fractions. The total determination uses controlled acid hydrolysis and glucose measurement, while the alpha determination uses an enzymatic route. The method accounts for shared glucose contributions as specified in its procedure. This is a defined analytical calculation, rather than a direct count of every beta-glucan molecule in an untouched mushroom.

The practical request is therefore the total result, alpha result and calculation basis behind the reported beta value. Some laboratories may not place every intermediate result on the short certificate. Ask whether the supporting record can provide them, together with method identity and units. The goal is to understand the result, not to replace the laboratory's validated procedure with a purchaser's simplified calculation.

When a method uses a total-minus-alpha relationship, both branches need suitable recovery and calculation. A change in either branch can change the final difference. If two COAs give different beta percentages, the intermediate results can indicate where the disagreement lies. Similar total results with different alpha results create a different investigation from different total results with similar alpha results. The headline difference alone hides that distinction.

In a difference-based method, the beta fraction depends on both analytical branches and their calculation conventions.

Use a numerical example only to explain the arithmetic. If a hypothetical method reports total glucan as 20 units and alpha glucan as five compatible units, the calculated difference is 15 units. These figures are not analytical expectations for any mushroom species. They also do not show that arbitrary results from unrelated methods can be subtracted. The fractions must belong to the same defined method and compatible basis for the calculation to have its intended meaning.

Ask how the procedure handles free glucose and other relevant contributions. A buyer should not assume that every molecule measured as glucose after hydrolysis originated from the desired polymer. The method's corrections and specificity are part of its suitability. A laboratory can explain those details for the sample it receives. The purchasing team should preserve that explanation rather than reduce the report to a broad claim about "active mushroom polysaccharides."

The difference result has uncertainty from the underlying measurements. A small change in a calculated value may not represent a meaningful material difference if the method's variability is similar in scale. Ask the laboratory how it interprets repeat results and whether the difference supports the proposed decision. More decimal places on the certificate do not create greater certainty about sample composition or the significance of a comparison.

A reported alpha fraction also should not become an automatic conclusion about the origin of the material. Its interpretation depends on species, sample form, method and relevant constituents. A percentage alone cannot authenticate a fruit body, identify a cultivation substrate or establish that a supplier added grain. If identity or adulteration is the purchasing concern, the buyer needs an appropriate investigation and evidence for that concern.

Keep non-glucan claims outside the analytical result. The assay does not establish a clinical effect, overall nutritional superiority, sensory quality or the performance of the mushroom in a cooked dish. Those are separate questions with different evidence needs. For the hypothetical GreenLand comparison, the immediate aim is narrower: identify how the two laboratories arrived at their beta figures and whether those figures describe comparable edible-mushroom samples.

A difference-based result depends on uncertainty in both branches. Intervals are qualitative and not on a shared numerical scale; they are not measured confidence limits or a method uncertainty estimate.

The certificate reviewer should check that intermediate and final values use the same stated basis before attempting to reproduce the calculation. Laboratories may round displayed results differently from internal calculations, so a small arithmetic difference on the short certificate needs clarification rather than accusation. Ask for the applicable calculation conventions. This keeps the enquiry focused on the result's meaning and avoids turning a formatting or rounding issue into an unsupported claim that the mushroom material or laboratory is unreliable.

Hydrolysis route affects recovery

Hydrolysis is the step that releases measurable units from the relevant material under the method's conditions. Its effectiveness depends on the procedure and sample. A result can therefore reflect analytical recovery as well as the amount of the analyte present. The buyer should read the named hydrolysis route and method version before deciding that a higher reported percentage proves a richer mushroom ingredient.

The 2016 method comparison found broadly similar acid-route results for many tested mushrooms, but different recovery for certain tested materials, including Ganoderma and Poria. Enzyme-only approaches often produced lower values in that comparison. These are bounded findings from the tested samples and procedures. They are not numerical composition expectations for frozen edible nameko, and they do not establish that every acid method is equivalent for every mushroom matrix.

The useful application lesson is to investigate method suitability when the hydrolysis routes differ. A laboratory using one acid arrangement and another using an enzymatic procedure may be measuring with different recovery characteristics. Keep those results as separate method-defined observations until evidence connects them. A purchaser cannot resolve the comparison by choosing whichever certificate gives the largest percentage or whichever method name sounds more rigorous.

Method edition matters too. A 2026 method update addresses issues including glucose loss during hydrolysis and interference in alpha-glucan determination. This reinforces the need to identify the actual validated procedure and its version. A report that merely cites a broad historical method family may omit changes relevant to interpretation. Ask the laboratory which procedure it follows and what evidence supports its use for the submitted sample.

Drying, grinding and extraction history should travel with the method record. They determine the material presented to the analytical procedure and may differ between two commercial forms. A laboratory needs enough sample information to select and apply its method appropriately. For a comparison, the purchaser should avoid treating an assay on a dried extract as equivalent to an assay on an as-received edible fruit body simply because both reports name beta-glucan.

Request the method and fraction records behind a calculated beta-glucan result.

Recovery evidence should be appropriate to the matrix and question. A laboratory can explain its checks, reference materials, repeatability and limitations without disclosing every proprietary operating detail. The buyer should ask what supports the method for the actual edible-mushroom sample. Evidence from a very different material may provide context, but it does not automatically qualify the submitted sample. That distinction matters before an assay becomes a release condition.

Do not use a universal conversion factor to reconcile incompatible hydrolysis routes. The published comparison does not supply a general multiplier that turns one method's result into another for every species and form. If the buyer needs a direct relationship, a controlled comparison using representative shared samples may be necessary. The study can justify asking that question; it cannot provide an untested correction for the purchasing spreadsheet.

For the hypothetical buyer, the next useful step is to obtain the hydrolysis and preparation descriptions from both laboratories. If the records remain different, a matched split-sample comparison can help identify whether method contributes to the disagreement. That experiment should be planned with the laboratories. GreenLand's supply discussion should keep the frozen edible-mushroom request clear while the buyer resolves the analytical basis needed for its intended specification.

Where an extract process is involved, separate extraction recovery from assay recovery. The amount transferred into an extract concerns the manufacturing process, while the amount measured after analytical hydrolysis concerns the laboratory procedure. A favorable percentage in a concentrated product does not identify how much constituent was recovered from its original input. The two questions require different denominators and records. For frozen edible mushrooms, do not introduce an extraction claim when the purchase concerns the whole food ingredient.

Ask for a comparable laboratory record

Request the full method identity rather than only a kit brand or the word "enzymatic." Include the procedure version, deviations or adaptations relevant to the submitted material, and the basis of the reported result. A commercial kit can be part of a well-controlled method, but its name alone does not show how the sample was prepared or whether the laboratory's implementation was suitable for that matrix.

The sample record should identify species, form, lot, collection and preparation. For a shared comparison, arrange representative sampling and traceable aliquots. If the buyer sends one laboratory selected mushroom pieces and another a different composite, the comparison contains a sampling difference before either assay starts. A split-sample plan can reduce that uncertainty, provided the composite itself represents the material whose purchase is being decided.

A representative chopped and mixed composite can provide matched portions for comparison. Equal drawn aliquots are a sampling illustration, not a species composition or an exact preparation instruction.

Ask for total glucan, alpha glucan and the calculated beta result where applicable, with compatible units and bases. Include measured moisture and the conversion calculation if the COA reports dry matter. A compact comparison table can reveal whether the values genuinely align. Leave missing information blank until it is obtained. Copying a moisture value or an intermediate result from another lot creates an apparently complete record with a false foundation.

Retain the laboratory's quality information and limitations. Repeatability, reporting limits and uncertainty can affect whether a difference is meaningful for a purchasing decision. If a sample required an unusual preparation or exceeded a method's normal scope, that should remain visible. A certificate is easier to read when it is brief, but the supporting record must still be available for technical review when the percentage becomes commercially important.

Accreditation is a useful part of selecting a laboratory, but check the relevant scope. A general accredited-laboratory statement does not establish that every offered assay is included or suitable for every matrix. Ask the laboratory which method and sample types its stated scope covers. Suitability and scope answer different questions, so the review should consider both rather than use a logo as the complete analytical assessment.

Compare the records before comparing the percentages. The useful fields are mushroom form, reporting basis, preparation, hydrolysis, method version, total, alpha and calculated beta. Mark whether they match, differ or remain unknown. This structure gives the purchasing team a reason for holding a numerical comparison open. It also makes the follow-up request precise, instead of asking a laboratory to defend a result without naming the point of disagreement.

Extraction recovery concerns the manufacturing process; analytical recovery concerns the assay. An extract route is conditional and is not an offered frozen-mushroom process.

If the team orders a matched repeat, agree who prepares the composite and how the aliquots are handled. Ask both laboratories to retain their method records and report the same required fields. A result from one shared composite can investigate method differences for that material. It does not describe the full variability of every future shipment, so a routine specification may need further representative-lot work.

At GreenLand, we would request the buyer's intended use and both complete reports, including hydrolysis route, total glucan, alpha glucan and wet or dry basis. We would also ask which edible-mushroom form the buyer wants to purchase. That information supports a practical discussion about samples and supply. It avoids presenting an unsupported beta-glucan figure as a routine promise for frozen nameko or implying an analytical capability that the enquiry has not established.

Ask the laboratory to explain what its routine quality checks can establish and what they cannot establish for the sample. A control can show that an analytical run behaved as expected, while representative sampling determines whether the tested material describes the lot. Both matter when the result becomes a purchasing limit. A clean assay record on an unrepresentative sample cannot establish the composition of the shipment, and a representative sample still needs a suitable analytical procedure.

Use the result for a defined purchase decision

Set a beta-glucan specification only when the intended application requires it and the method supports it. A compositional-development project may justify a defined analytical target. A normal culinary purchase may have a different priority. The buyer should be able to explain how the result changes its ingredient choice, formulation or release decision. A percentage collected without that purpose can create disputes without improving the product.

Where a limit is needed, write the sample form, method version and basis into the specification. State whether the requirement concerns as-received or dry-matter material and how representative sampling is performed. The total and alpha records can support interpretation where the method uses their difference. A limit that omits these fields may reject one report and accept another even when they describe the same underlying material on different bases.

Agree how to handle a result near the proposed limit. The decision should consider the method's uncertainty and repeatability, as well as the agreed sampling arrangement. A repeat from the same prepared aliquot is different from a new composite from the lot. The specification should make the relevant follow-up understandable to both parties. Otherwise, repeated testing can become a search for a passing value instead of an investigation.

A separate bulk view of frozen nameko mushroom fruit bodies.

Keep the ordinary edible-mushroom requirements in view. Species, product form, condition, size, sensory suitability, packing and traceability remain relevant to the food application. A beta-glucan result does not replace those requirements. If the mushroom performs poorly in the intended dish, a favorable analytical percentage does not resolve that problem. The composition assay should add useful information to the purchase rather than displace the product brief.

Avoid health promises from the percentage. An analytical result describes a method-defined constituent in a sample. It does not demonstrate a clinical outcome, a medicinal effect or an approved consumer claim. The intended food and market have their own claim requirements. For this GreenLand enquiry, the useful conclusion concerns comparability and ingredient selection, without turning frozen edible mushrooms into a supplement proposition.

A purchasing decision may reasonably remain open while method details are obtained. The buyer can continue discussing the edible-mushroom supply requirements and arrange representative samples, while keeping the disputed compositional limit under review. This prevents an unresolved COA comparison from being treated as a proven supplier-quality difference. Once the sample, method and basis align, the team has a firmer basis for evaluating the remaining numerical difference.

Representative shared material helps isolate method differences; moisture is measured separately for the applicable basis conversion.

The approval record should say which question the evidence answered. It might establish comparable results for one split sample, identify a reporting-basis difference, or show that two methods still need matrix-specific comparison. Each conclusion supports a different next step. State any untested material range and avoid describing a one-sample method comparison as validation of every future lot or every edible mushroom species.

For the hypothetical GreenLand buyer, send the intended product use, the two reports and the basis of each result. Include actual mushroom form, hydrolysis route, total and alpha measurements, moisture information and wet or dry reporting basis. We can then discuss the frozen nameko request against a defined application. The final beta-glucan number becomes useful when the buyer can explain how it was obtained and what purchase decision it is meant to support.

Purchasing should record the reason for any added assay requirement alongside its technical definition. If the customer requires the figure for a defined formulation project, retain that brief and the agreed method. If the reason changes, review the requirement rather than keep an expensive test by habit. This helps the supplier understand what evidence is useful and gives the buyer a consistent explanation of why the percentage affects acceptance of this edible-mushroom product.